comparemela.com

Latest Breaking News On - Margin expansion for orthopedics focused - Page 1 : comparemela.com

Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact - Enovis (NYSE:ENOV)

Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent acquisitions impact.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.